CLINICAL MANAGEMENT OF DISCREPANCIES BETWEEN FIB-4 AND LIVER STIFFNESS MEASUREMENT IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

被引：0

作者：

Rabbat, Joseph ^{[1
]}

Lee, Hye Won ^{[2
]}

Yip, Terry Cheuk-Fung ^{[1
]}

Lin, Huapeng ^{[3
]}

Tsochatzis, Emmanuel ^{[4
]}

Petta, Salvatore ^{[5
]}

Bugianesi, Elisabetta ^{[6
]}

Yoneda, Masato ^{[7
]}

Zheng, Ming-Hua ^{[8
]}

Hagstrom, Hannes ^{[9
]}

Boursier, Jerome ^{[10
]}

Calleja, Jose Luis ^{[11
]}

Goh, George Boon-Bee ^{[12
]}

Chan, Wah Kheong ^{[13
]}

Gallego-Duran, Rocio ^{[14
]}

Sanyal, Arun ^{[15
]}

de Ledinghen, Victor ^{[16
]}

Newsome, Philip ^{[17
]}

Fan, Jian-Gao ^{[3
]}

Castera, Laurent ^{[18
]}

Lai, Michelle ^{[19
]}

Fournier, Celine ^{[16
]}

Wong, Grace ^{[1
]}

Pennisi, Grazia ^{[5
]}

Armandi, Angelo ^{[6
]}

Nakajima, Atsushi ^{[20
]}

Liu, Wen-Yue ^{[8
]}

Shang, Ying ^{[21
]}

Saint Loup, Marc De ^{[10
]}

Llop, Elba ^{[11
]}

Teh, Kevin ^{[12
]}

Romero, Carmen Lara ^{[14
]}

Asgharpour, Amon ^{[22
]}

Mahgoub, Sara ^{[23
]}

Chan, Mandy ^{[16
]}

Canivet, Clemence ^{[10
]}

Romero-Gomez, Manuel ^{[14
]}

Kim, Seung Up ^{[2
]}

机构：

[1] Chinese Univ Hong Kong, Hong Kong, Peoples R China

[2] Yonsei Univ, Coll Med, Seoul, South Korea

[3] Shanghai Jiao Tong Univ, Shanghai, Peoples R China

[4] UCL, London, England

[5] Univ Palermo, Palermo, Italy

[6] Univ Turin, Turin, Italy

[7] Yokohama City Univ, Yokohama, Kanagawa, Japan

[8] Wenzhou Med Univ, Wenzhou, Peoples R China

[9] Karolinska Univ Hosp, Solna, Sweden

[10] Angers Univ Hosp, Angers, France

[11] Hosp Univ Puerta de Hierro, Madrid, Spain

[12] Singapore Gen Hosp, Singapore, Singapore

[13] Univ Malaya, Kuala Lumpur, Malaysia

[14] Virgen Del Rocio Univ Hosp, Seville, Spain

[15] Virginia Commonwealth Univ, Richmond, VA 23284 USA

[16] Echosens, Paris, France

[17] Kings Coll London, London, England

[18] Univ Paris Cite, Paris, France

[19] Beth Israel Deaconess Med Ctr, Boston, MA USA

[20] Natl Hosp Org Yokohama Med Ctr, Yokohama, Kanagawa, Japan

[21] Karolinska Inst, Solna, Sweden

[22] VCU Sch Med, Richmond, VA USA

[23] Univ Birmingham, Birmingham B15 2TT, W Midlands, England

来源：

HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

757

引用

页码：S566 / S567

页数：2

共 50 条

[21] ASSOCIATION BETWEEN US ABDOMEN, FIB-4, AND VCTE DETERMINED STEATOSIS AND DISEASE SEVERITY IN A CANADIAN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) COHORT
Bera, Chinmay
Hamdan, Nashla
Kosick, Heather
Allam, Nader
Fakhriyehasl, Mina
Jhaveri, Kartik
Patel, Keyur
HEPATOLOGY, 2024, 80 : S451 - S451
[22] Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Kang, Yeo-Wool
Baek, Yang-Hyun
Moon, Sang-Yi
DIAGNOSTICS, 2024, 14 (22)
[23] Metabolic Dysfunction-Associated Steatotic Liver Disease
Ali, Sajjadh M. J.
Lai, Michelle
ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
[24] FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
Avares-da-Silva, Mario Reis
Vargas, Marcia da Silva
Rabie, Soheyla Mohd Souza
Jonko, Gabriella
Riedel, Patricia Gabriela
Longo, Larisse
Goncalves, Marcelo Rodrigues
Luft, Vivian Cristine
Joveleviths, Dvora
ANNALS OF HEPATOLOGY, 2025, 30 (01)
[25] EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Wong, Vincent Wai-Sun
Ratziu, Vlad
Bugianesi, Elisabetta
Francque, Sven
Zelber-Sagi, Shira
Valenti, Luca
Roden, Michael
Schick, Fritz
Yki-Jarvinen, Hannele
Gastaldelli, Amalia
Vettor, Roberto
Fruhbeck, Gema
Dicker, Dror
JOURNAL OF HEPATOLOGY, 2024, 81 (03) : 492 - 542
[26] EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
OBESITY FACTS, 2024, 17 (04)
[27] Implications of Protein and Sarcopenia in the Prognosis, Treatment, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Singh, Avneet
Buckholz, Adam
Kumar, Sonal
Newberry, Carolyn
NUTRIENTS, 2024, 16 (05)
[28] Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Elshaer, Amani
Chascsa, David M. H.
Lizaola-Mayo, Blanca C.
LIFE-BASEL, 2024, 14 (07):
[29] The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B
Patmore, Lesley A.
van Eekhout, Kirsi
Koc, oezguer M.
de Knegt, Robert J.
Janssen, Harry L. A.
Brouwer, Willem P.
Kramer, Matthijs
Honkoop, Pieter
de Bruijne, Joep
Boland, Greet J.
Postma, Douwe F.
Blokzijl, Hans
de Man, Robert A.
Takkenberg, R. Bart
Sonneveld, Milan J.
LIVER INTERNATIONAL, 2025, 45 (03)
[30] Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
Mellemkjaer, Anders
Kjaer, Mikkel Breinholt
Haldrup, David
Gronbaek, Henning
Thomsen, Karen Louise
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 28 - 34

← 1 2 3 4 5 →